|
π
|
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
11 auth.
J. Zaknun,
L. Bodei,
J. MuellerβBrand,
Marianne Pavel,
R. Baum,
Dieter HΓΆrsch,
...
M. O'dorisio,
T. M. OβDorisiol,
J. Howe,
M. Cremonesi,
D. Kwekkeboom
|
9 |
2013 |
9
π
|
|
π
|
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
11 auth.
L. Bodei,
M. Kidd,
G. Paganelli,
C. Grana,
I. Drozdov,
M. Cremonesi,
...
Christopher Lepensky,
D. Kwekkeboom,
R. Baum,
E. Krenning,
I. Modlin
|
8 |
2014 |
8
π
|
|
π
|
Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
12 auth.
L. Bodei,
M. Cremonesi,
C. Grana,
N. Fazio,
S. Iodice,
S. Baio,
...
M. Bartolomei,
D. Lombardo,
M. Ferrari,
M. Sansovini,
M. Chinol,
G. Paganelli
|
8 |
2011 |
8
π
|
|
π
|
Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study
10 auth.
L. Bodei,
M. Cremonesi,
S. Zoboli,
C. Grana,
M. Bartolomei,
P. Rocca,
...
M. Caracciolo,
H. MaΜcke,
M. Chinol,
G. Paganelli
|
8 |
2003 |
8
π
|
|
π
|
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
9 auth.
L. Bodei,
M. Cremonesi,
M. Ferrari,
M. Pacifici,
C. Grana,
M. Bartolomei,
...
S. Baio,
M. Sansovini,
G. Paganelli
|
8 |
2008 |
8
π
|
|
π
|
Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
11 auth.
C. Cicco,
M. Cremonesi,
Alberto Luini,
M. Bartolomei,
C. Grana,
G. Prisco,
...
V. Galimberti,
Paolo Calza,
G. Viale,
Umberto Veronesi,
Giovanni Paganelli
|
7 |
1998 |
7
π
|
|
π
|
Safety of sentinel node biopsy in pregnant patients with breast cancer.
12 auth.
O. Gentilini,
M. Cremonesi,
G. TrifirΓ²,
M. Ferrari,
S. Baio,
M. Caracciolo,
...
A. Rossi,
A. Smeets,
V. Galimberti,
A. Luini,
G. Tosi,
G. Paganelli
|
7 |
2004 |
7
π
|
|
π
|
Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours
7 auth.
L. Bodei,
M. Cremonesi,
C. Grana,
P. Rocca,
M. Bartolomei,
M. Chinol,
...
G. Paganelli
|
7 |
2004 |
7
π
|
|
π
|
Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide
12 auth.
G. Paganelli,
S. Zoboli,
M. Cremonesi,
L. Bodei,
M. Ferrari,
C. Grana,
...
M. Bartolomei,
F. Orsi,
C. De Cicco,
H. MaΜcke,
M. Chinol,
F. D. De Braud
|
7 |
2001 |
7
π
|
|
π¦
|
Dosimetry in Peptide radionuclide receptor therapy: a review.
M. Cremonesi,
M. Ferrari,
L. Bodei,
G. Tosi,
G. Paganelli
|
7 |
2006 |
7
π¦
|
|
π
|
Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin
12 auth.
G. Paganelli,
C. Grana,
M. Chinol,
M. Cremonesi,
C. De Cicco,
F. D. De Braud,
...
C. Robertson,
S. Zurrida,
C. Casadio,
S. Zoboli,
A. Siccardi,
U. Veronesi
|
7 |
1999 |
7
π
|
